Literature DB >> 15299626

Structure of diferric duck ovotransferrin at 2.35 A resolution.

A Rawas1, H Muirhead, J Williams.   

Abstract

The structure of diferric duck ovotransferrin (DOT) has been determined and refined at a resolution of 2.35 A. The DOT structure, which contains two iron binding sites, is similar to the known transferrin and lactoferrin structures. The two iron-binding sites, one in the N-terminal lobe and one in the C-terminal lobe of the molecule, are similar but not identical. The main differences between the three known structures lie in the relative orientations of the N- and C-lobes with respect to each other. In the DOT structure the large aromatic side chain of Phe322 in the N-lobe packs against the conserved residue Gly387 in the C-lobe. This interaction is at the centre of the interface between the two lobes and could play a crucial role in determining their relative orientation. Other differences between the structures occur in the surface loops and in the peptide connecting the two lobes. The final crystallographic model consists of 5309 protein atoms (686 residues), two Fe(3+) ions, two (bi)carbonate ions and three carbohydrate moities. 318 water molecules have been added to the model. The final R factor is 0.22 for 25 400 observed reflections between 10 and 2.35 A resolution.

Entities:  

Year:  1996        PMID: 15299626     DOI: 10.1107/S0907444996000212

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  2 in total

1.  The crystal structure of iron-free human serum transferrin provides insight into inter-lobe communication and receptor binding.

Authors:  Jeremy Wally; Peter J Halbrooks; Clemens Vonrhein; Mark A Rould; Stephen J Everse; Anne B Mason; Susan K Buchanan
Journal:  J Biol Chem       Date:  2006-06-22       Impact factor: 5.157

Review 2.  A structural comparison of human serum transferrin and human lactoferrin.

Authors:  Jeremy Wally; Susan K Buchanan
Journal:  Biometals       Date:  2007-01-11       Impact factor: 2.949

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.